Valuation: Proto Script Pharmaceutical Corp.

Market Cap 1.97M 1.76M 1.62M 1.47M 2.75M 187M 2.79M 19.51M 7.73M 97.76M 7.38M 7.22M 308M P/E 2015 *
-
P/E 2016 -41.4x
Enterprise Value 2.01M 1.8M 1.66M 1.51M 2.82M 191M 2.86M 19.99M 7.91M 100M 7.56M 7.4M 316M EV / Sales 2015 *
-
EV / Sales 2016 394x
Free-Float
89.82%
Yield 2015 *
-
Yield 2016 -
1 day-50.00%
3 months-50.00%
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 1.0E-6
2.2
Manager TitleAgeSince
Chief Executive Officer 58 2016-06-28
Change 5-day change 1-year change 3-year change Capi.($)
-50.00%-.--%-66.67%-98.00% 5.69K
-1.55%+1.32%+17.43%+72.23% 749B
+0.03%+4.87%+17.43%+78.74% 88.98B
-1.09%+6.72%+20.32%+175.31% 68.04B
-0.90%+0.56%-18.27%+10.74% 48.78B
-3.24%-1.84%-3.87%+83.27% 46.22B
-0.27%-4.07%+35.37%+738.12% 43.51B
-0.44%+3.29%+8.60%+36.68% 32.17B
-1.58%+2.16%+43.63%+76.91% 26.82B
-1.89%+4.86%-60.17%-56.31% 26.51B
Average -6.09%+1.82%-0.62%+111.77% 112.98B
Weighted average by Cap. -1.37%+1.74%+14.43%+98.47%

Financials

2015 2016
Net sales 881K 787K 727K 659K 1.23M 83.67M 1.25M 8.75M 3.46M 43.84M 3.31M 3.24M 138M 789K 705K 651K 590K 1.1M 74.9M 1.12M 7.83M 3.1M 39.24M 2.96M 2.9M 124M
Net income -145K -130K -120K -109K -203K -13.79M -207K -1.44M -571K -7.22M -545K -534K -22.78M -7.18M -6.41M -5.93M -5.37M -10.05M -682M -10.21M -71.3M -28.23M -357M -26.96M -26.38M -1.13B
Net Debt 27.07K 24.17K 22.33K 20.24K 37.86K 2.57M 38.49K 269K 106K 1.35M 102K 99.43K 4.24M 47.78K 42.67K 39.42K 35.72K 66.83K 4.54M 67.94K 474K 188K 2.38M 179K 176K 7.49M
Logo Proto Script Pharmaceutical Corp.
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Employees
13
  1. Stock Market
  2. Stocks
  3. PSCR Stock